{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:57:32Z","timestamp":1781881052249,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Blepharoptosis, or drooping of the upper eyelid, is commonly encountered by dermatologic surgeons due to aging, medical conditions, periocular procedures, and\/or inadvertent neurotoxin administration. Proper recognition and management are critical for both functional and cosmetic outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To review clinically relevant anatomy, diagnostic evaluation, and nonsurgical treatments for acquired ptosis, emphasizing considerations specific to dermatologic practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>A literature review of PubMed and Embase identified English-language studies and clinical trials addressing the diagnosis and management of blepharoptosis, with emphasis on nonsurgical and dermatologic applications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Key diagnostic tools include the marginal reflex distance 1, levator function testing, and standardized preprocedure and postprocedure photography. Oxymetazoline 0.1% demonstrates modest but statistically significant improvement in marginal reflex distance 1 and superior visual field improvement in randomized trials. Off-label adrenergic agents and targeted pretarsal botulinum toxin injections may offer adjunctive benefits, although supporting evidence is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Dermatologic surgeons are positioned to identify and manage mild acquired ptosis using validated metrics and nonsurgical options. Selective botulinum toxin placement can be considered in selected cases; supporting evidence remains limited. Appropriately identifying cases that need referral for surgical repair will also benefit patient care by improving vision, daily function, and cosmesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000005227","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:11:49Z","timestamp":1781878309000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Acquired Blepharoptosis for the Dermatologic Surgeon: Recognition, Assessment, and Nonsurgical Management"],"prefix":"10.1097","author":[{"given":"Sam","family":"Fathizadeh","sequence":"first","affiliation":[{"name":"College of Medicine, University of Illinois at Chicago, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorry E.","family":"Aitkens","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Louisiana State University (LSU) Health, New Orleans, Louisiana;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah D.","family":"Sherman","sequence":"additional","affiliation":[{"name":"Sherman Aesthetic Center, Nashville, Tennessee;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Carruthers","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Hooper","sequence":"additional","affiliation":[{"name":"Audubon Dermatology, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"R1-20260619","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00266-003-0127-5","article-title":"Ptosis: causes, presentation, and management","volume":"27","author":"Finsterer","year":"2003","journal-title":"Aesthet Plast Surg"},{"key":"R2-20260619","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1598188","article-title":"Clinical evaluation of blepharoptosis: distinguishing age-related ptosis from masquerade conditions","volume":"31","author":"Latting","year":"2017","journal-title":"Semin Plast Surg"},{"key":"R3-20260619","first-page":"e55970","article-title":"Treatment of full eyelid ptosis following Botox injection: a case report","volume":"16","author":"Musharbash","year":"2024","journal-title":"Cureus"},{"key":"R4-20260619","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jamaophthalmol.2020.3812","article-title":"Association of oxymetazoline hydrochloride, 0.1%, solution administration with visual field in acquired ptosis: a pooled analysis of 2 randomized clinical trials","volume":"138","author":"Slonim","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R5-20260619","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1472-8206.2009.00805.x","article-title":"Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline","volume":"24","author":"Haenisch","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"R7-20260619","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/00002341-199903000-00005","article-title":"Distribution of adrenergic receptor subtypes in the retractor muscles of the upper eyelid","volume":"15","author":"Esmaeli-Gutstein","year":"1999","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R8-20260619","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/17469899.2015.991389","article-title":"Controversies and advances in the management of congenital ptosis","volume":"10","author":"Mokhtarzadeh","year":"2015","journal-title":"Expert Rev Ophthalmol"},{"key":"R9-20260619","article-title":"Upper eyelid ptosis revisited","volume":"6","author":"Sudhakar","year":"2009","journal-title":"Am J Clin Med"},{"key":"R10-20260619","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/01676830.2013.788673","article-title":"Relative incidence of blepharoptosis subtypes in an oculoplastics practice at a tertiary care center","volume":"32","author":"Lim","year":"2013","journal-title":"Orbit"},{"key":"R11-20260619","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/kjo.kjo_2_19","article-title":"Ptosis: evaluation and management","volume":"31","author":"Sruthi","year":"2019","journal-title":"Kerala J Ophthalmol"},{"key":"R12-20260619","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/IOP.0000000000000903","article-title":"The phenylephrine test revisited","volume":"34","author":"Barsegian","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R13-20260619","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/DSS.0000000000004066","article-title":"Getting the correct cosmetic photographs every time","volume":"50","author":"Fathizadeh","year":"2024","journal-title":"Dermatol Surg"},{"key":"R14-20260619","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/j.ophtha.2011.09.029","article-title":"Functional indications for upper eyelid ptosis and blepharoplasty surgery: a report by the American Academy of Ophthalmology","volume":"118","author":"Cahill","year":"2011","journal-title":"Ophthalmology"},{"key":"R15-20260619","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1090820X10374108","article-title":"Evaluation and management of unilateral ptosis and avoiding contralateral ptosis","volume":"30","author":"Zoumalan","year":"2010","journal-title":"Aesthet Surg J"},{"key":"R16-20260619","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/01.IOP.0000143714.10858.D4","article-title":"Effect of unilateral blepharoptosis repair on contralateral eyelid position","volume":"20","author":"Erb","year":"2004","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R17-20260619","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/IOP.0000000000000843","article-title":"Upper eyelid response to topical 0.5% apraclonidine","volume":"34","author":"Kirkpatrick","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R18-20260619","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/bjo.79.12.1098","article-title":"Long term effect of apraclonidine","volume":"79","author":"Araujo","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"R19-20260619","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0404.1993.tb05516.x","article-title":"Topical naphazoline in treatment of myopathic ptosis","volume":"87","author":"Uncini","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"R20-20260619","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/WNO.0000000000000826","article-title":"Treatment of ptosis using brimonidine tartrate for anterior laminectomy-induced horner syndrome","volume":"40","author":"Rehmani","year":"2020","journal-title":"J Neuroophthalmol"},{"key":"R21-20260619","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/01.PRS.0000142744.55379.8D","article-title":"Temporary management of upper lid ptosis, lid malposition, and eyelid fissure asymmetry with botulinum toxin type A","volume":"114","author":"Fagien","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"R22-20260619","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/asj\/sjac139","article-title":"Is it worth using botulinum toxin injections for the management of mild to moderate blepharoptosis?","volume":"42","author":"Ludwig","year":"2022","journal-title":"Aesthet Surg J"},{"key":"R23-20260619","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s00266-024-04584-z","article-title":"Botulinum toxin: a non-surgical approach for non-myasthenic mild-to-moderate blepharoptosis treatment","volume":"49","author":"D'Emilio","year":"2025","journal-title":"Aesthet Plast Surg"},{"key":"R24-20260619","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/01676830.2017.1383475","article-title":"Scleral contact lenses for the management of complicated ptosis","volume":"37","author":"Katsoulos","year":"2018","journal-title":"Orbit"},{"key":"R25-20260619","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.ico.0000148311.94180.6b","article-title":"Scleral contact lenses: the expanding role","volume":"24","author":"Pullum","year":"2005","journal-title":"Cornea"},{"key":"R26-20260619","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/IOP.0b013e3181d07408","article-title":"Scleral contact lens usage in patients with complex blepharoptosis","volume":"27","author":"Shah-Desai","year":"2011","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000005227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:11:52Z","timestamp":1781878312000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000005227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000005227","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}